L’INESSS a actuellement le mandat d’évaluer, en vue d’une couverture publique, une immunothérapie génique qui utilise les cellules immunitaires du patient (lymphocytes T) po
Dr. Connors’ involvement with Lymphoma Canada dates back to our embryonic stage.
Lori Hygaard – Primary Registered Nurse, Regional Cancer Care Northwest, Thunder Bay Regional Health Sciences Centre
Sabina Vohra-Miller has an educational background in clinical pharmacology and toxicology. She previously worked in biotech as a medical advisor.
Lymphoma Canada is preparing submissions for the pan-Canadian Oncology Drug Review (pCODR) for two upcoming drug reviews for PTCL: